Literature DB >> 11067960

Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus.

M Odendahl1, A Jacobi, A Hansen, E Feist, F Hiepe, G R Burmester, P E Lipsky, A Radbruch, T Dörner.   

Abstract

In patients with active systemic lupus erythematosus (SLE), a marked B lymphocytopenia was identified that affected CD19(+)/CD27(-) naive B cells more than CD19(+)/CD27(+) memory B cells, leading to a relative predominance of CD27-expressing peripheral B cells. CD27(high)/CD38(+)/CD19(dim)/surface Ig(low)/CD20(-)/CD138(+) plasma cells were found at high frequencies in active but not inactive SLE patients. Upon immunosuppressive therapy, CD27(high) plasma cells and naive CD27(-) B cells were markedly decreased in the peripheral blood. Mutational analysis of V gene rearrangements of individual B cells confirmed that CD27(+) B cells coexpressing IgD were memory B cells preferentially using V(H)3 family members with multiple somatic mutations. CD27(high) plasma cells showed a similar degree of somatic hypermutation, but preferentially employed V(H)4 family members. These results indicate that there are profound abnormalities in the various B cell compartments in SLE that respond differently to immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11067960     DOI: 10.4049/jimmunol.165.10.5970

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  189 in total

1.  Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.

Authors:  Clayton A White; Egest J Pone; Tonika Lam; Connie Tat; Ken L Hayama; Guideng Li; Hong Zan; Paolo Casali
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

2.  B lymphocytes are resistant to death receptor 5-induced apoptosis.

Authors:  Roslyn N Crowder; Hong Zhao; W Winn Chatham; Tong Zhou; Robert H Carter
Journal:  Clin Immunol       Date:  2011-01-28       Impact factor: 3.969

3.  A genetic lesion that arrests plasma cell homing to the bone marrow.

Authors:  Loren D Erickson; Ling-Li Lin; Biyan Duan; Laurence Morel; Randolph J Noelle
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-10       Impact factor: 11.205

Review 4.  Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies.

Authors:  A Vossenkämper; P M K Lutalo; J Spencer
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 5.  T cells that promote B-Cell maturation in systemic autoimmunity.

Authors:  Jason S Weinstein; Sairy G Hernandez; Joe Craft
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

Review 6.  B cells as therapeutic targets in SLE.

Authors:  Iñaki Sanz; F Eun-Hyung Lee
Journal:  Nat Rev Rheumatol       Date:  2010-06       Impact factor: 20.543

Review 7.  B Cells, Antibodies, and More.

Authors:  William Hoffman; Fadi G Lakkis; Geetha Chalasani
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 8.237

8.  Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations.

Authors:  Zachary S Wallace; Hamid Mattoo; Mollie Carruthers; Vinay S Mahajan; Emanuel Della Torre; Hang Lee; Maria Kulikova; Vikram Deshpande; Shiv Pillai; John H Stone
Journal:  Ann Rheum Dis       Date:  2014-05-09       Impact factor: 19.103

9.  Human immunoglobulin selection associated with class switch and possible tolerogenic origins for C delta class-switched B cells.

Authors:  Nai-Ying Zheng; Kenneth Wilson; Xiaojian Wang; Angela Boston; Grant Kolar; Stephen M Jackson; Yong-Jun Liu; Virginia Pascual; J Donald Capra; Patrick C Wilson
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

10.  Contribution and underlying mechanisms of CXCR4 overexpression in patients with systemic lupus erythematosus.

Authors:  Li-Dan Zhao; Di Liang; Xiang-Ni Wu; Yang Li; Jing-Wen Niu; Chen Zhou; Li Wang; Hua Chen; Wen-Jie Zheng; Yun-Yun Fei; Fu-Lin Tang; Yong-Zhe Li; Feng-Chun Zhang; Wei He; Xue-Tao Cao; Xuan Zhang
Journal:  Cell Mol Immunol       Date:  2016-09-26       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.